Determination on Adding Cancer, or a Certain Type of Cancer, to the List of WTC-Related Health Conditions, 44933 [2011-18754]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 144 / Wednesday, July 27, 2011 / Notices
Office of Insurance Programs for New
York, co-chair the SNAC.
Role of the National Advisory Council
The National Advisory Council for
Healthcare Research and Quality is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director, Agency for
Healthcare Research and Quality
(AHRQ), on matters related to AHRQ’s
conduct of its mission including
providing guidance on (A) Priorities for
health care research, (B) the field of
health care research including training
needs and information dissemination on
health care quality and (C) the role of
the Agency in light of private sector
activity and opportunities for public
private partnerships.
The Council is composed of members
of the public, appointed by the
Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
The final agenda will be available on
the AHRQ Web site at https://
www.AHRQ.gov no later than August 1,
2011.
Dated: July 8, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011–18791 Filed 7–26–11; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–227]
Determination on Adding Cancer, or a
Certain Type of Cancer, to the List of
WTC-Related Health Conditions
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the ‘‘First
Periodic Review of Scientific and
Medical Evidence Related to Cancer for
the World Trade Center Health
Program.’’ The Review can be found at:
sroberts on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:08 Jul 26, 2011
Jkt 223001
https://www.cdc.gov/niosh/topics/wtc/
prc/prc-1.html.
Background: The James Zadroga 9/11
Health and Compensation Act of 2010
(Pub. L. 111–347), Title XXXIII of the
Public Health Service Act, 124 Stat.
3623 (codified at 42 U.S.C. 300mm–
300mm–61) requires in Section 300mm–
22(a)(5)(A) that the Administrator of the
World Trade Center (WTC) Health
Program ‘‘periodically conduct a review
of all available scientific and medical
evidence, including findings and
recommendations of Clinical Centers of
Excellence, published in peer-reviewed
journals to determine if, based on such
evidence, cancer or a certain type of
cancer should be added to the
applicable list of WTC-related health
conditions.’’
The first periodic Review of Cancer
provides a summary of the current
scientific and medical findings in the
peer-reviewed literature about
exposures resulting from the September
11, 2001 terrorist attacks in New York
City and cancer studies. The review
discusses criteria that have been used
previously to assist in weighing the
scientific evidence to determine if a
causal association exists between
exposure and cancer. The review
summarizes input from the public on
three questions regarding conditions
relating to cancer for consideration
under the WTC Health Program, as
requested in the Federal Register on
March 8, 2011 (76 FR 12740) and
modified on March 29, 2011 (76 FR
17421). See https://www.cdc.gov/niosh/
docket/archive/docket227.html.
The review also provides reports from
the Mount Sinai School of Medicine, the
Bureau of Health Services of the Fire
Department of New York City, the WTC
Health Registry of the New York City
Department of Health and Mental
Hygiene and the New York State
Department of Health about cancer
studies ongoing or planned.
Based on the scientific and medical
findings in the peer-reviewed literature
reported in the first periodic Review of
Cancer for the WTC Health Program,
insufficient evidence exists at this time
to propose a rule to add cancer, or a
certain type of cancer, to the List of
WTC-Related Health Conditions found
at 42 U.S.C. 300mm–22(a)(3) through (4)
and 300mm–32(b).
FOR FURTHER INFORMATION CONTACT:
Jessica Bilics, NIOSH, Patriots Plaza 1,
395 E Street, SW., Suite 9200,
Washington, DC 20201, E-mail
WTC@cdc.gov.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
44933
Dated: July 19, 2011.
John Howard,
Administrator, World Trade Center Health
Program; and Director, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention.
[FR Doc. 2011–18754 Filed 7–26–11; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Statement of Organization, Functions,
and Delegations of Authority
Part F of the Statement of
Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services, Centers for Medicare &
Medicaid Services (CMS), (Federal
Register, Vol. 75, No. 56, pp. 14176–
14178, dated March 24, 2010; as
amended at Vol. 76, No. 17, p. 4703,
dated January 26, 2011; as amended at
Vol. 76, No. 75, pp. 21908–21909, dated
April 19, 2011) is amended to reflect the
establishment of the Office of Minority
Health.
Part F is described below:
• Section FC. 10 (Organization) reads
as follows:
Office of the Administrator (FC)
Office of Equal Opportunity and Civil
Rights (FCA)
Office of Legislation (FCC)
Office of the Actuary (FCE)
Office of Strategic Operations and
Regulatory Affairs (FCF)
Office of Clinical Standards and Quality
(FCG)
Center for Medicare (FCH)
Center for Medicaid, CHIP and Survey
& Certification (FCJ)
Center for Strategic Planning (FCK)
Center for Program Integrity (FCL)
Chief Operating Officer (FCM)
Office of Minority Health (FCN)
Center for Medicare and Medicaid
Innovation (FCP)
Federal Coordinated Health Care Office
(FCQ)
Center for Consumer Information and
Insurance Oversight (FCR)
Office of Public Engagement (FCS)
Office of Communications (FCT)
• Section FC. 20 (Functions) reads as
follows:
Office of Minority Health (FCN)
• Serves as the principal advisor and
coordinator to the Agency for the
special needs of minority and
disadvantaged populations.
• Provides leadership, vision and
direction to address HHS and CMS
E:\FR\FM\27JYN1.SGM
27JYN1
]]>Agencies
[Federal Register Volume 76, Number 144 (Wednesday, July 27, 2011)]
[Notices]
[Page 44933]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18754]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-227]
Determination on Adding Cancer, or a Certain Type of Cancer, to
the List of WTC-Related Health Conditions
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces the availability of the ``First Periodic Review of Scientific
and Medical Evidence Related to Cancer for the World Trade Center
Health Program.'' The Review can be found at: https://www.cdc.gov/niosh/topics/wtc/prc/prc-1.html.
Background: The James Zadroga 9/11 Health and Compensation Act of
2010 (Pub. L. 111-347), Title XXXIII of the Public Health Service Act,
124 Stat. 3623 (codified at 42 U.S.C. 300mm-300mm-61) requires in
Section 300mm-22(a)(5)(A) that the Administrator of the World Trade
Center (WTC) Health Program ``periodically conduct a review of all
available scientific and medical evidence, including findings and
recommendations of Clinical Centers of Excellence, published in peer-
reviewed journals to determine if, based on such evidence, cancer or a
certain type of cancer should be added to the applicable list of WTC-
related health conditions.''
The first periodic Review of Cancer provides a summary of the
current scientific and medical findings in the peer-reviewed literature
about exposures resulting from the September 11, 2001 terrorist attacks
in New York City and cancer studies. The review discusses criteria that
have been used previously to assist in weighing the scientific evidence
to determine if a causal association exists between exposure and
cancer. The review summarizes input from the public on three questions
regarding conditions relating to cancer for consideration under the WTC
Health Program, as requested in the Federal Register on March 8, 2011
(76 FR 12740) and modified on March 29, 2011 (76 FR 17421). See https://www.cdc.gov/niosh/docket/archive/docket227.html.
The review also provides reports from the Mount Sinai School of
Medicine, the Bureau of Health Services of the Fire Department of New
York City, the WTC Health Registry of the New York City Department of
Health and Mental Hygiene and the New York State Department of Health
about cancer studies ongoing or planned.
Based on the scientific and medical findings in the peer-reviewed
literature reported in the first periodic Review of Cancer for the WTC
Health Program, insufficient evidence exists at this time to propose a
rule to add cancer, or a certain type of cancer, to the List of WTC-
Related Health Conditions found at 42 U.S.C. 300mm-22(a)(3) through (4)
and 300mm-32(b).
FOR FURTHER INFORMATION CONTACT: Jessica Bilics, NIOSH, Patriots Plaza
1, 395 E Street, SW., Suite 9200, Washington, DC 20201, E-mail
WTC@cdc.gov.
Dated: July 19, 2011.
John Howard,
Administrator, World Trade Center Health Program; and Director,
National Institute for Occupational Safety and Health, Centers for
Disease Control and Prevention.
[FR Doc. 2011-18754 Filed 7-26-11; 8:45 am]
BILLING CODE 4163-19-P
